Concepts and challenges of biosimilars to mitigate the oncology drug expenses

Concepts and challenges of biosimilars to mitigate the oncology drug expenses

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Tania, Umme
Rannpháirtithe:	Haque , Md. Aminul
Formáid:	Tráchtas
Teanga:	en_US
Foilsithe / Cruthaithe:	Brac University 2021
Ábhair:	Biosimilars Interchangeability Cancer therapy Monoclonal antibodies Biologic medicines Comparability exercise
Rochtain ar líne:	http://hdl.handle.net/10361/15111

Míreanna comhchosúla

Biosimilar in lymphoma treatment
de réir: Tanisha, Mehrin Haque
Foilsithe / Cruthaithe: (2021)

Biosimilar insulins: a potential option in the treatment of Diabetes
de réir: Tabassum, Turana
Foilsithe / Cruthaithe: (2022)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
de réir: Tania, Umme
Foilsithe / Cruthaithe: (2023)

Advancement of Antibody-Drug conjugates in cancer treatment: A review
de réir: Sagar, Baejid Hossain
Foilsithe / Cruthaithe: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
de réir: Fred, Namanda Rogers
Foilsithe / Cruthaithe: (2021)

A review on targeted therapies for lung cancer
de réir: Ashraf, Anushey
Foilsithe / Cruthaithe: (2023)

Osteoarthritis: a multi-disciplinary factual review
de réir: Subah, Nowshin
Foilsithe / Cruthaithe: (2021)

Biosimilars: A revolution for biologics in the pharmaceutical industry
de réir: Moreino, Shannon Sherwin
Foilsithe / Cruthaithe: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
de réir: Moya, Amena Khatun
Foilsithe / Cruthaithe: (2023)

Targeted therapeutic options in the treatment of Breast Cancer
de réir: Alam, Kazi Tasnuva
Foilsithe / Cruthaithe: (2022)

In vivo propagation of monoclonal antibodies in ascites fluid produced in BALB/c mice: characterization and diagnostic application for the identification of Vibrio cholerae O1
de réir: Chowdhury, Mashiat Nawar
Foilsithe / Cruthaithe: (2018)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
de réir: Choki, Kinley
Foilsithe / Cruthaithe: (2024)

Post Covid-19 health indications of Covid-19 patients
de réir: Khan, Tanzim
Foilsithe / Cruthaithe: (2022)

Recent advancement of biologics in Asthma
de réir: Evan, Al- Shahriar
Foilsithe / Cruthaithe: (2022)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
de réir: Lubaba, Anikah
Foilsithe / Cruthaithe: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
de réir: Ratu, Tabassum
Foilsithe / Cruthaithe: (2024)

A comprehensive review on drug repurposing in cancer treatment
de réir: Sarkar, Onusree
Foilsithe / Cruthaithe: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
de réir: Chakraborty, Anuradha
Foilsithe / Cruthaithe: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
de réir: Hoque, Syeda Mehren
Foilsithe / Cruthaithe: (2024)

Breast cancer therapy through Liposomal drug delivery system
de réir: Ome, Nusrat Jahan
Foilsithe / Cruthaithe: (2024)

An improved chromosome sorting algorithm by permutation group-based inverted block-interchanges
de réir: Tabassum, Afrida, et al.
Foilsithe / Cruthaithe: (2018)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
de réir: Akter, Anika
Foilsithe / Cruthaithe: (2022)

Risk of cancer associated with antihypertensive drugs
de réir: Iqbal, Adnan
Foilsithe / Cruthaithe: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
de réir: Jahan, Nusrat
Foilsithe / Cruthaithe: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
de réir: Rattry, Faria Rahman
Foilsithe / Cruthaithe: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
de réir: Rahman, Sanjida
Foilsithe / Cruthaithe: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
de réir: Hasan, Sakib
Foilsithe / Cruthaithe: (2024)

Immunotherapy in the Management of Lung Cancer
de réir: Tasnim, Humayra
Foilsithe / Cruthaithe: (2022)

Biosimilars
Foilsithe / Cruthaithe: (2013)

Biosimilars

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
de réir: Dowla, Rumana, et al.
Foilsithe / Cruthaithe: (2022)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
de réir: Razna, Amrin Islam
Foilsithe / Cruthaithe: (2019)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
de réir: Kamal, Tasnova
Foilsithe / Cruthaithe: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
de réir: Parvez, Safi
Foilsithe / Cruthaithe: (2023)

Sugar based biopolymers in nanomedicine: a review
de réir: Juthy, Afrin Rahman
Foilsithe / Cruthaithe: (2024)

A review on combinatorial therapies in Melanoma
de réir: Ahmmed, Md. Kawsar
Foilsithe / Cruthaithe: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
de réir: Hasan, Amit
Foilsithe / Cruthaithe: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
de réir: Nahar, Kamrun
Foilsithe / Cruthaithe: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
de réir: Nashrah, Zannatul
Foilsithe / Cruthaithe: (2023)

Food, nutrition, physical activity and the prevention of cancer : a global perspective : a project of World Cancer Research Fund International.
Foilsithe / Cruthaithe: (2007)